TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
← New search
Home›Stocks›ALVO
ALVO logo

ALVO

Alvotech

Next earnings Aug 19, 2026 · consensus $-0.01 EPS, $135M rev

Sell
$3.61
▼ -2.96%
$3.61▼ -60.50%
over 1Y
L $3.00H $9.81
Today-3.0%
1W+3.7%
1M+20.3%
3M-1.1%
YTD-27.8%
1Y-60.5%
OverviewValuationQualityFilings
Rating
Sell
Quality
F
Valuation
Fair value
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Buy

Mixed signals in the latest filings.

Alvotech shows limited reported revenue.

On these fundamentals, the SEC-figure screen rates ALVO a SELL.

Is ALVO a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread~60d expiry
  • Long put 3.5 @ ~0.47 est
  • Short put 3 @ ~0.24 est
debit $23max +$27max −$23BE 3.27

SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.

Open in the calculator →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financials · annual, by fiscal year

No income data filed.

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$1.22B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt—
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+3.4%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-07-012026-07-01open ↗SCHEDULE 13D/AFiling2026-06-30open ↗6-KPeriod ending 2026-06-182026-06-18open ↗6-KPeriod ending 2026-06-162026-06-17open ↗424B5Filing2026-06-16open ↗FWPFiling2026-06-16open ↗FWPFiling2026-06-15open ↗424B5Filing2026-06-15open ↗6-KPeriod ending 2026-06-152026-06-15open ↗6-KPeriod ending 2026-03-312026-06-08open ↗6-KPeriod ending 2026-06-042026-06-04open ↗6-KPeriod ending 2026-05-112026-05-11open ↗

Quality score

F
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial health—
MomentumF
3.0052-week9.81
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals

Frequently asked

Is Alvotech (ALVO) a buy?
ALVO currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
What is Alvotech's quality score?
ALVO scores 23.313201648429718/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001898416, latest 6-K filed 2026-07-01) · EODHD · as of 6/18/2026, 12:12:07 PM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 18, 2026, 8:12 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Recent news

market news →
Alvotech (ALVO) Stock May Be Undervalued Following Its $125 Million OfferingBullish
finance.yahoo.com· 2026-07-02
Alvotech’s US$240 Million Capital Boost Might Change The Case For Investing In Alvotech (ALVO)Bullish
finance.yahoo.com· 2026-07-02
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Wednesday Ahead of Fed Chair Warsh's International DebutBullish
finance.yahoo.com· 2026-07-01
Biotech firm Alvotech expands capital access with $75M term loan facilityBullish
seekingalpha.com· 2026-07-01
Alvotech further strengthens liquidity by securing term loan facility of $75 millionBullish
finance.yahoo.com· 2026-07-01
Alvotech (ALVO): 10 Penny Stocks With Explosive Growth PotentialBullish
finance.yahoo.com· 2026-06-20

Vs tracked universe

compare →

1195 tracked peers · median

TENK Score23 vs 67
Revenue growth— vs 7.5%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.2